Waters, 186004713, Oasis Peptide Method Development 96 well µElution Plate, 2 mg, 30 µm, 1/pk

Name: Oasis Peptide Method Development 96 well µElution Plate, 2 mg, 30 µm, 1/pk
Brand: Waters
SKU: 186004713

Catalog Number: 186004713

Pricing

Send an RFQ.

View RFQ List

Category

Sample Filtration Devices

Pack Size1/pk

CollectionsWaters Service Parts & Kits for ACQUITY, Alliance & Arc Waters Sample Preparation: SPE, Syringe Filters & QuEChERS Waters Standards & Reagents for LC/MS, HPLC & GC

Description

Oasis Peptide Method Development µElution Plate is designed to simplify the process of sample preparation for the analysis of therapeutic peptides in plasma. The 96-well plate format contains six rows each of two Oasis mixed-mode, ion-exchange chemistries: a strong exchanger (MAX) and a weak cation exchanger (WCX). Sample preparation method development can be quickly and easily achieved with the use of a single SPE protocol. The Oasis Peptide µElution Method Development Plate is sold separately or as a component of the UPLC Therapeutic Peptide Method Development Kit (176001835) and the HPLC Therapeutic Peptide Method Development Kit (176001836).

Specifications

General

UNSPSC	41115712
Brand	Oasis
Product Type	Solid Phase Extraction
Units per Package	1 pk
Chemistry	Method Development
Endcapped	No
Format	96-well µElution Plate
Mass Spec Compatibility	Yes
Mode	Mixed mode
Particle Size	30 µm
Pore Size	80 Å
Sorbent Substrate	Copolymer
Sorbent Weight	2 mg
Water Wettable	Yes
pH Range Min	0 pH
pH Range Max	14 pH
Material	Polypropylene
Number of Wells	96

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.